出典:Wikipedia
出典:『Wikipedia』 (2011/07/01 08:58 UTC 版)
Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma and hematological malignancies.